WEBINAR | COVID-19 Diagnostics: Their applications and key unanswered questions in low-resource settings

Since the outbreak of COVID19, diagnostics have played a crucial role in the responseeven as health systems have struggled with stock-outs of test kits, delays in reporting test results, and overwhelmed laboratoriesHowever, knowledge about the various types of tests for SARS-CoV-2 – and their interpretation and applications – is still evolving. Many unanswered questions remain 

Molecular tests have largely remained the gold standard for diagnosis of COVID-19but the costs, complexity, turnaround time, and supply issues for these tests have limited or prevented universal access to diagnosisAmidst the increased demand for testing, many companies are developing and validating novel COVID-19 diagnostics, including rapid antigen tests, which are seen by many as a solution for mass testing. In the absence of adequate testing materials in some countries, there have also been calls to consider wider uses for serological tests, which evaluate whether someone has had a COVID-19 infection by detecting antibodies.   

In this webinar, experts from the Virology, Immunology & Diagnostics Working Group of the COVID-19 Clinical Research Coalition will:  

  • Give a brief overview of the working group and its current work to identify priority clinical research questions in the domain of virology, immunology, and diagnostics.   
  • Provide an update on the various COVID-19 diagnostics and their applications, and comment on some of the challenges of their use in low-resource settings and related research questions. 

Watch the recording


To register for this event please visit the following URL: https://zoom.us/webinar/register/6716058716921/WN_2VgcS-E4TJ2HVr6lBGi6Zw →



10 December 2020 - 14:30 - 15:30 CEST

Event Category